Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $11.34 million. The enterprise value is $1.20 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INTS has 2.65 million shares outstanding. The number of shares has increased by 221.96% in one year.
| Current Share Class | 2.65M |
| Shares Outstanding | 2.65M |
| Shares Change (YoY) | +221.96% |
| Shares Change (QoQ) | +8.76% |
| Owned by Insiders (%) | 5.30% |
| Owned by Institutions (%) | 7.24% |
| Float | 2.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.86 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -207.37% and return on invested capital (ROIC) is -131.61%.
| Return on Equity (ROE) | -207.37% |
| Return on Assets (ROA) | -90.39% |
| Return on Invested Capital (ROIC) | -131.61% |
| Return on Capital Employed (ROCE) | -110.50% |
| Weighted Average Cost of Capital (WACC) | 20.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.53M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.97% in the last 52 weeks. The beta is 3.06, so INTS's price volatility has been higher than the market average.
| Beta (5Y) | 3.06 |
| 52-Week Price Change | -63.97% |
| 50-Day Moving Average | 5.19 |
| 200-Day Moving Average | 7.90 |
| Relative Strength Index (RSI) | 22.82 |
| Average Volume (20 Days) | 28,666 |
Short Selling Information
The latest short interest is 75,334, so 2.84% of the outstanding shares have been sold short.
| Short Interest | 75,334 |
| Short Previous Month | 72,900 |
| Short % of Shares Out | 2.84% |
| Short % of Float | 3.10% |
| Short Ratio (days to cover) | 2.29 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.10M |
| Pretax Income | -10.69M |
| Net Income | -10.69M |
| EBITDA | n/a |
| EBIT | -11.10M |
| Earnings Per Share (EPS) | -$5.82 |
Full Income Statement Balance Sheet
The company has $10.25 million in cash and $102,000 in debt, with a net cash position of $10.14 million or $3.83 per share.
| Cash & Cash Equivalents | 10.25M |
| Total Debt | 102,000 |
| Net Cash | 10.14M |
| Net Cash Per Share | $3.83 |
| Equity (Book Value) | 9.98M |
| Book Value Per Share | 3.93 |
| Working Capital | 8.66M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -9.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -221.96% |
| Shareholder Yield | -221.96% |
| Earnings Yield | -94.29% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for INTS is $24.80, which is 479.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.80 |
| Price Target Difference | 479.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 19, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Feb 19, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |